BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 17989534)

  • 1. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?
    Jacobsen L; Valovirta E
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):556-60. PubMed ID: 17989534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S; Lau S; Valovirta E
    Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The connection between allergic rhinitis and bronchial asthma.
    Corren J
    Curr Opin Pulm Med; 2007 Jan; 13(1):13-8. PubMed ID: 17133119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
    Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
    Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
    Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
    J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of allergology evaluation for the treatment of asthma and rhinosinusitis].
    Michel O
    Rev Med Brux; 2008 Sep; 29(4):393-9. PubMed ID: 18949994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The health economics of allergen immunotherapy.
    Hankin CS; Cox L; Bronstone A
    Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing progression of allergic rhinitis: the role of specific immunotherapy.
    Fiocchi A; Fox AT
    Arch Dis Child Educ Pract Ed; 2011 Jun; 96(3):91-100. PubMed ID: 21047834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of sublingual immunotherapy.
    Scadding G; Durham S
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of immunotherapy in allergic rhinitis.
    Jayasekera NP; Toma TP; Williams A; Rajakulasingam K
    Biomed Pharmacother; 2007 Jan; 61(1):29-33. PubMed ID: 17189678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific immunotherapy in pollen allergy.
    Wallner M; Briza P; Thalhamer J; Ferreira F
    Curr Opin Mol Ther; 2007 Apr; 9(2):160-7. PubMed ID: 17458170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy: an option in the management of occupational asthma?
    Sastre J; Quirce S
    Curr Opin Allergy Clin Immunol; 2006 Apr; 6(2):96-100. PubMed ID: 16520672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy: clinical trials--optimal trial and clinical outcomes.
    Bousquet PJ; Demoly P; Passalacqua G; Canonica GW; Bousquet J
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):561-6. PubMed ID: 17989535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.